MS4078: Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient
with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin
MS4078: Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient
with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin